A phase II trial of 4-demethoxydaunorubicin in refractory epithelial ovarian cancer
- 1 May 1986
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 24 (1) , 23-26
- https://doi.org/10.1016/0090-8258(86)90004-1
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Long-term survival after chemotherapy for advanced epithelial ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1984
- Single-agent adriamycin followed by combination hexamethylmelamine-cyclophosphamide for advanced ovarian carcinomaGynecologic Oncology, 1982
- Reporting results of cancer treatmentCancer, 1981
- Adriamycin in ovarian cancer patients resistant to cyclophosphamidePublished by Elsevier ,1978
- ADRIAMYCIN THERAPY FOR ADVANCED OVARIAN CARCINOMA RECURRENT AFTER CHEMOTHERAPY1978